3[1]Hardy J,Selkoe DJ.The arnyloid hypothesis of Alzheimer'S disease:progress and problems on the road to therapeutics[J].Science,2002;297(5580):353-356.
4[2]Schwab JM,Monnier PP.Central nervous system injury-induced repulsive guidance molecule expression in the adult hunum brain[J].Archives of Neurology,2005;62(10):1561-1568.
5[3]Katsuhiko H,Masashi F.RGMa inhibition promotes axonal growth and recovery after spinal cord injury[J].The Joumal Of Cell Biology,2006:173(1):47-58.
6[4]Nakamum S,Murayama N,Noshita T,et al.Progressive brain dysfunction following intracerebroventricular infusion of beta(1-42)-amyloid peptide[J].Brain Res,2001;912(2):128-136.
7[5]Brinks H,Conrad S,Vogt J,et al.The repulsive guidance molecule RGMa iS involved in the formation of afferent connections in the dentate gyms[J].J Neurosei,2004;24:3862-3869.
8[6]Steven P,Xu H,Megan L Kerr,et al.The p-amyloid protein of Alzheimer'S disease increases neuronal CRMP-2 phosphorylation by a Rho-GTP mechanism[J].Brain,2008:131(1):90-108.
9[7]Zhou Y,Su Y,Baolin L,et al.Nonsteroidal anti-inflammatory drags can lower amyloidagenic A?42 by inhibiting rhqfJ Science,2003;302:1215-1217.
10[8]Park JH,Gimbel DA,GrandPre T,et al.Alzheimer precursor prot ein interaction with the nogo-66 receptor reduces amyloid-beta plaque deposition[J].Ncurosei,2006;26(5):1386-1395.
